2021
DOI: 10.1111/nyas.14704/v2/response1
|View full text |Cite
|
Sign up to set email alerts
|

Author response for "IL‐38–mediated NLRP3/caspase‐1 inhibition is a disease‐modifying treatment for TMJ inflammation"

Help me understand this report

This publication either has no citations yet, or we are still processing them

Set email alert for when this publication receives citations?

See others like this or search for similar articles